MXPA01009468A - Tratamiento de hipertension pulmonar. - Google Patents
Tratamiento de hipertension pulmonar.Info
- Publication number
- MXPA01009468A MXPA01009468A MXPA01009468A MXPA01009468A MXPA01009468A MX PA01009468 A MXPA01009468 A MX PA01009468A MX PA01009468 A MXPA01009468 A MX PA01009468A MX PA01009468 A MXPA01009468 A MX PA01009468A MX PA01009468 A MXPA01009468 A MX PA01009468A
- Authority
- MX
- Mexico
- Prior art keywords
- pulmonary hypertension
- treatment
- anorectic
- medications
- monohydrate
- Prior art date
Links
- 208000002815 pulmonary hypertension Diseases 0.000 title abstract 2
- UWAOJIWUVCMBAZ-UHFFFAOYSA-N [1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-dimethylazanium;chloride Chemical compound Cl.C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UWAOJIWUVCMBAZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000001539 anorectic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se usa un compuesto de la formula (I): (ver formula) o una sal farmaceuticamente aceptable del mismo, donde R1 y R2 son independientemente H o metilo (por ejemplo, clorhidrato de N,N-dimetil-1-[1-(4-clorofenil)ciclobutil]-3-metilbutialina, opcionalmente en la forma de su monohidrato), para tratar la hipertension pulmonar, en particular en pacientes que toman ciertos medicamentos anoreticos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12560499P | 1999-03-19 | 1999-03-19 | |
| PCT/US2000/007124 WO2000056312A1 (en) | 1999-03-19 | 2000-03-17 | Treatment of pulmonary hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01009468A true MXPA01009468A (es) | 2004-03-19 |
Family
ID=22420534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01009468A MXPA01009468A (es) | 1999-03-19 | 2000-03-17 | Tratamiento de hipertension pulmonar. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6403650B1 (es) |
| EP (1) | EP1162964A1 (es) |
| JP (1) | JP2002539250A (es) |
| AU (1) | AU3757200A (es) |
| CA (1) | CA2366652A1 (es) |
| MX (1) | MXPA01009468A (es) |
| WO (1) | WO2000056312A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8614247B2 (en) | 2003-04-10 | 2013-12-24 | Institut National De La Sante Et De La Recherche Medicale | Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof |
| WO2004089348A2 (en) * | 2003-04-10 | 2004-10-21 | Assistance Publique - Hopitaux De Paris | Use of a serotonin transporter inhibitor for the treatment of pulmonary hypertension |
| US20050131074A1 (en) * | 2003-08-04 | 2005-06-16 | Beckman Kristen M. | Methods for treating metabolic syndrome |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA821577B (en) | 1981-04-06 | 1983-03-30 | Boots Co Plc | Therapeutic agents |
| GB8531071D0 (en) | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
| GB8704777D0 (en) | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
| JP2675573B2 (ja) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | 脳機能改善剤 |
| IE61928B1 (en) | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
| US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
| GB9705428D0 (en) | 1997-03-15 | 1997-04-30 | Knoll Ag | Therapeutic agents |
-
2000
- 2000-03-17 JP JP2000606217A patent/JP2002539250A/ja not_active Withdrawn
- 2000-03-17 MX MXPA01009468A patent/MXPA01009468A/es unknown
- 2000-03-17 CA CA002366652A patent/CA2366652A1/en not_active Abandoned
- 2000-03-17 WO PCT/US2000/007124 patent/WO2000056312A1/en not_active Ceased
- 2000-03-17 EP EP00916474A patent/EP1162964A1/en not_active Withdrawn
- 2000-03-17 US US09/527,815 patent/US6403650B1/en not_active Expired - Fee Related
- 2000-03-17 AU AU37572/00A patent/AU3757200A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6403650B1 (en) | 2002-06-11 |
| AU3757200A (en) | 2000-10-09 |
| EP1162964A1 (en) | 2001-12-19 |
| WO2000056312A1 (en) | 2000-09-28 |
| CA2366652A1 (en) | 2000-09-28 |
| JP2002539250A (ja) | 2002-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA01009404A (es) | Metodo para tratar trastornos de alimentacion. | |
| IL128851A (en) | Pharmaceutical composition for lowering the uric acid level in the human body | |
| WO2000056315A8 (en) | Treatment of pain | |
| IL177626A0 (en) | Pharmaceutical compositions for treating sleep apnoea | |
| MXPA01009467A (es) | Metodo para controlar el aumento de peso asociado con farmacos terapeuticos. | |
| MXPA01009468A (es) | Tratamiento de hipertension pulmonar. | |
| MXPA01009469A (es) | Tratamiento para disminuir la adhesividad de las plaquetas. | |
| BG105999A (en) | Treatment of osteoarthritis | |
| MXPA01009463A (es) | Tratamiento de hernia hiatial. | |
| SE0203778D0 (sv) | A new oral immediated release dosage form | |
| MXPA04006888A (es) | Prucaloprida-n-oxido. | |
| MXPA01009462A (es) | Tratamiento de calculos biliares. | |
| MXPA01009465A (es) | Perdida de peso despues del embarazo. | |
| MXPA01009470A (es) | Tratamiento de ciertos canceres asociados con el aumento de peso. | |
| BG105996A (en) | Method of treating eating disorders |